Peter Polverini
Peter Polverini
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Interleukin-8 as a macrophage-derived mediator of angiogenesis
AE Koch, PJ Polverini, SL Kunkel, LA Harlow, LA DiPietro, VM Elner, ...
Science 258 (5089), 1798-1801, 1992
Biological action of leptin as an angiogenic factor
MR Sierra-Honigmann, AK Nath, C Murakami, G Garcı́a-Cardeña, ...
Science 281 (5383), 1683-1686, 1998
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
SJ Leibovich, PJ Polverini, HM Shepard, DM Wiseman, V Shively, ...
Nature 329 (6140), 630-632, 1987
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
RM Strieter, PJ Polverini, SL Kunkel, DA Arenberg, MD Burdick, J Kasper, ...
Journal of Biological Chemistry 270 (45), 27348-27357, 1995
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
DJ Good, PJ Polverini, F Rastinejad, MM Le Beau, RS Lemons, ...
Proceedings of the National Academy of Sciences 87 (17), 6624-6628, 1990
Activated macrophages induce vascular proliferation
PJ Polverini, RS Cotran, MA Gimbrone, ER Unanue
Nature 269 (5631), 804-806, 1977
Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.
NN Nissen, PJ Polverini, AE Koch, MV Volin, RL Gamelli, LA DiPietro
The American journal of pathology 152 (6), 1445, 1998
Scatter factor induces blood vessel formation in vivo.
DS Grant, HK Kleinman, ID Goldberg, MM Bhargava, BJ Nickoloff, ...
Proceedings of the National Academy of Sciences 90 (5), 1937-1941, 1993
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
JE Nör, J Christensen, DJ Mooney, PJ Polverini
The American journal of pathology 154 (2), 375-384, 1999
Engineering tumors with 3D scaffolds
C Fischbach, R Chen, T Matsumoto, T Schmelzle, JS Brugge, PJ Polverini, ...
Nature methods 4 (10), 855-860, 2007
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
SS Tolsma, OV Volpert, DJ Good, WA Frazier, PJ Polverini, N Bouck
Journal of Cell Biology 122 (2), 497-511, 1993
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
AE Koch, MM Halloran, CJ Haskell, MR Shah, PJ Polverini
Nature 376 (6540), 517-519, 1995
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
F Rastinejad, PJ Polverini, NP Bouck
Cell 56 (3), 345-355, 1989
Interleukin-8. A corneal factor that induces neovascularization.
RM Strieter, SL Kunkel, VM Elner, CL Martonyi, AE Koch, PJ Polverini, ...
The American journal of pathology 141 (6), 1279, 1992
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
DA Arenberg, SL Kunkel, PJ Polverini, M Glass, MD Burdick, RM Strieter
The Journal of clinical investigation 97 (12), 2792-2802, 1996
Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.
PJ Polverini, SJ Leibovich
Laboratory investigation; a journal of technical methods and pathology 51 (6 …, 1984
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
DR Smith, PJ Polverini, SL Kunkel, MB Orringer, RI Whyte, MD Burdick, ...
The Journal of experimental medicine 179 (5), 1409-1415, 1994
Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis
A Pandey, H Shao, RM Marks, PJ Polverini, VM Dixit
Science 268 (5210), 567-569, 1995
Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
EG Van Meir, PJ Polverini, VR Chazin, HJS Huang, N de Tribolet, ...
Nature genetics 8 (2), 171-176, 1994
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
DA Arenberg, SL Kunkel, PJ Polverini, SB Morris, MD Burdick, MC Glass, ...
The Journal of experimental medicine 184 (3), 981-992, 1996
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20